VNRX Financials 07/16/2014 18:31:49 VolitionRX Lt

VNRX Financials 07/16/2014 18:31:49
VolitionRX Ltd
Period Ending Dec 31, 2013 Dec 31, 2012 Dec 31, 2011 Aug 31, 2010
Total Revenue - 55 - -
Cost of Revenue - - - -
Gross Profit - 55 - -
Operating Expenses
Research and Development 2,504 2,773 1,521 -
Sales, General and Admin. 1,722 1,365 1,087 11
Non-Recurring Items 350 - - -
Other - - - -
Operating Income (4,576) (4,083) (2,608) (11)
Income From Continuing Operations
Add'l Income/Expense Items 866 - - -
Earnings Before Interest and Tax (3,710) (4,083) (2,608) (11)
Interest Expense - - - -
Earnings Before Tax (3,710) (4,083) (2,608) (11)
Income Tax - - - -
Minority Interest - - - -
Equity Earnings Unconsolidated Subsidiary - - - -
Net Income Cont. Operations (3,710) (4,083) (2,608) (11)
Non Recurring Events
Discontinued Operations - - - -
Extraordinary Items - - - -
Effect of Accounting Changes - - - -
Other Items - - - -
Net Income (3,710) (4,083) (2,608) (11)
Preferred Stock and Other Adjustments - - - -
Net Income Applicable to Common Shareholders (3,710) (4,083) (2,608) (11)